UniProtKB/Swiss-Prot Q04726: Variant p.Ala229Val

Transducin-like enhancer protein 3
Gene: TLE3
Feedback?

Variant information Variant position:

229 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Alanine (A) to Valine (V) at position 229 (A229V, p.Ala229Val). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from small size and hydrophobic (A) to medium size and hydrophobic (V) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs1057864 [ dbSNP | Ensembl ]

Sequence information Variant position:

229 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

772 The length of the canonical sequence.
Location on the sequence:

RASEKHRGSADYSMEAKKRK A EEKDSLSRYDSDGDKSDDLV The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         RASEKHRGSADYSMEAKKRKAEEKDSLSRYDSDGDKSDDLV

Mouse                         RASEKHRGSADYSMEAKKRKAEEKDSLSRYDSDGDKSDDLV

Rat                           RASEKHRGSADYSMEAKKRKAEEKDSLSRYDSDGDKSDDLV

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 772	Transducin-like enhancer protein 3
Region	185 – 347	Disordered
Region	200 – 268	CcN domain
Compositional bias	208 – 251	Basic and acidic residues
Modified residue	211 – 211	Phosphoserine
Modified residue	217 – 217	Phosphoserine
Modified residue	232 – 232	N6-acetyllysine
Modified residue	240 – 240	Phosphoserine
Modified residue	245 – 245	Phosphoserine

Literature citations
Human homologs of a Drosophila enhancer of split gene product define a novel family of nuclear proteins.
Stifani S.; Blaumueller C.M.; Redhead N.J.; Hill R.E.; Artavanis-Tsakonas S.;
Nat. Genet. 2:119-127(1992)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANT VAL-229;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.